4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-23-037167
See Remarks sold 2,259 shares at an average $12.68 ($28,649)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McNeill Jonathan See Remarks | 2023-06-12 | Sale 10b5-1 | −1,000 | $13.00 | $13,000 | 64,391 | D |
| McNeill Jonathan See Remarks | 2023-06-13 | Sale 10b5-1 | −1,259 | $12.43 | $15,649 | 63,132 | D |
| Open-market sales · 2,259 sh · avg $12.68 · $28,649 | |||||||
Loading xslF345X04/doc4.xml…